Aro Biotherapeutics rakes in $13 mln
Philadelphia-based Aro Biotherapeutics, a new biotech company, has raised $13 million in funding. The investors were Johnson & Johnson Innovation – JJDC Inc and BioMotiv LLC.
11 December 2018•1 min read
Philadelphia-based Aro Biotherapeutics, a new biotech company, has raised $13 million in funding. The investors were Johnson & Johnson Innovation – JJDC Inc and BioMotiv LLC.
